Infantile Neuroaxonal Dystrophy: Case Report and Review of Literature

Alian Fatima1, Shahd A Abuhijleh1, Abdul Fatah1

  • 1Department of Pediatrics, Saqr Hospital, Ras Al-Khaimah P.O. Box 5450, United Arab Emirates.

PubMed

Insights

Infantile neuroaxonal dystrophy (INAD) is a rare genetic disorder causing progressive neurodegeneration in children. This case report highlights diagnostic challenges and emphasizes the need for increased awareness and genetic counseling for INAD.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Infantile neuroaxonal dystrophy (INAD) is a rare, severe neurodegenerative disorder affecting 1:1,000,000 children.
  • Pathogenic variants in the PLA2G6 gene on chromosome 22q13.1 cause INAD, with symptom onset typically between 6-18 months.
  • The condition leads to developmental regression, muscle weakness, dementia, and ultimately life-limiting respiratory failure within 5-10 years.

Observation:

  • This report details a 9-year-old Pakistani girl diagnosed with INAD.
  • Her symptoms included recurrent chest infections, developmental regression, speech loss, paralysis, hypertension, and respiratory distress.
  • Diagnosis was confirmed via brain MRI and genetic testing, despite overlapping clinical features presenting diagnostic challenges.

Findings:

  • The case underscores the diagnostic complexities of INAD due to its varied clinical presentation.
  • Genetic testing confirmed pathogenic variants in PLA2G6 as the underlying cause.
  • The patient's progression highlights the severe and debilitating nature of the disease.

Implications:

  • Increased awareness of INAD among healthcare practitioners is crucial for timely diagnosis.
  • Genetic counseling is vital for couples at risk of passing on INAD-associated gene variants.
  • Further research into potential genetic therapies and improved supportive care strategies is warranted.